The Effect of RNS60 on ALS Biomarkers

NCT03456882 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

147

Enrollment

OTHER

Sponsor class

Conditions

Amyotrophic Lateral Sclerosis

Interventions

DRUG: RNS60

Sponsor

Mario Negri Institute for Pharmacological Research

Collaborators

[object Object]
[object Object]